imatinib mesylate has been researched along with Dyspepsia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Breccia, M; Colafigli, G; Di Prima, A; Diverio, D; Efficace, F; FoĆ , R; Latagliata, R; Martelli, M; Pepe, S; Scalzulli, E; Stocchi, F | 1 |
1 other study(ies) available for imatinib mesylate and Dyspepsia
Article | Year |
---|---|
Switch from branded to generic imatinib: impact on molecular responses and safety in chronic-phase chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Substitution; Drugs, Generic; Dyspepsia; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |